Vamifeport
Vamifeport (VIT-2763) is a novel orally active inhibitor that targets iron transport proteins and reduces markers of hemolysis in the SCD Townes model.VIT-2763 improves anemia and erythropoiesis, ameliorates vascular inflammation, and can be studied in β-thalassemia.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
408.43
Molecular Formula
C21H21FN6O2
Notes
Research use only, not for human use.
Receptor
Ferroptosis
CAS Number
2095668-10-1
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
28416126 3 x 1.0μg DNA
METTL3 CRISPRa sgRNA lentivector (set of three targets)(Rat)
Ask
View Details 
MBS7221902-01 48 Well
Sheep Phosphatidylcholine-sterol acyltransferase (LCAT) ELISA Kit
Ask
View Details 
MBS7221902-02 96 Well
Sheep Phosphatidylcholine-sterol acyltransferase (LCAT) ELISA Kit
Ask
View Details 
MBS7221902-03 5x 96 Well
Sheep Phosphatidylcholine-sterol acyltransferase (LCAT) ELISA Kit
Ask
View Details